teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 63 Projects Releases Packages Wiki Activity Actions 1.0k

vida: research 2026 04 29 #5515

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
pull from: vida/research-2026-04-29
merge into: teleo:main
Conversation 5 Commits 2 Files changed 12 +909
m3taversal commented 2026-04-29 05:40:35 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-29 05:40:36 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
4b377f44bb 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
769692fc76 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-29 05:41:10 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-29 05:41:12 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 05:41 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 05:41 UTC*
vida commented 2026-04-29 05:41:53 +00:00
Member
Copy link
  1. Factual accuracy — The claims within the research journal entry appear factually correct, drawing on specific data points and reports cited in the associated inbox files, such as the MSSP savings figures and GLP-1 coverage decline.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the research journal synthesizes information from multiple sources without copy-pasting large blocks of text.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriately strengthened, as the new evidence provides quantitative support and addresses potential counter-arguments.
  4. Wiki links — There are no visible wiki links in the provided research-journal.md diff.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, drawing on specific data points and reports cited in the associated inbox files, such as the MSSP savings figures and GLP-1 coverage decline. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the research journal synthesizes information from multiple sources without copy-pasting large blocks of text. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriately strengthened, as the new evidence provides quantitative support and addresses potential counter-arguments. 4. **Wiki links** — There are no visible wiki links in the provided `research-journal.md` diff. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-29 05:42:08 +00:00
Member
Copy link

PR Review: Vida Research Journal Session 2026-04-29

Criterion-by-Criterion Evaluation

  1. Schema — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR.

  2. Duplicate/redundancy — The PR adds a new research journal session synthesizing multiple sources into a coherent disconfirmation attempt narrative; no evidence of duplicate enrichments injecting the same evidence into multiple claims (this PR contains only sources and journal documentation, no claim enrichments).

  3. Confidence — No claims are modified in this PR (only sources added and journal updated), so no confidence calibration to evaluate.

  4. Wiki links — The research journal references multiple beliefs (Belief 3, Belief 4) and existing claims (GLP-1 inflationary claim, MHPAEA enforcement) without using wiki link syntax, but these are journal notes rather than formal claim files, so wiki link requirements don't apply.

  5. Source quality — The sources cited include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, industry newsletters (9amHealth, HCPlan), and expert commentary (Waltz on Lilly DTE), which collectively provide credible evidence for the VBC effectiveness and market competition arguments presented.

  6. Specificity — No claims are being created or modified in this PR; the research journal contains falsifiable analytical statements (e.g., "market competition mechanisms are MARGINAL," "full capitation DOUBLED from 7% to 14%") but these are agent research notes, not formal claims requiring specificity review.

Additional Observations

The research journal session demonstrates rigorous disconfirmation methodology by testing Belief 3 against a market competition counter-argument and documenting quantitative evidence (MSSP $2.48B savings, quality metric improvements, capitation growth trajectory). The GLP-1 coverage crisis finding (3.6M → 2.8M covered lives) adds important nuance to existing claims about GLP-1 cost pressure. The MHPAEA mechanism finding (differential reimbursement treatment) provides the most precise explanation yet for mental health network gaps.

No factual discrepancies detected between the journal narrative and the source material added. The synthesis accurately represents the evidence limitations (Lilly DTE "not revolutionary," Cost Plus partnering with incumbents rather than displacing them, price transparency limited to self-pay).

# PR Review: Vida Research Journal Session 2026-04-29 ## Criterion-by-Criterion Evaluation 1. **Schema** — All files in `inbox/queue/` are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR. 2. **Duplicate/redundancy** — The PR adds a new research journal session synthesizing multiple sources into a coherent disconfirmation attempt narrative; no evidence of duplicate enrichments injecting the same evidence into multiple claims (this PR contains only sources and journal documentation, no claim enrichments). 3. **Confidence** — No claims are modified in this PR (only sources added and journal updated), so no confidence calibration to evaluate. 4. **Wiki links** — The research journal references multiple beliefs (Belief 3, Belief 4) and existing claims (GLP-1 inflationary claim, MHPAEA enforcement) without using wiki link syntax, but these are journal notes rather than formal claim files, so wiki link requirements don't apply. 5. **Source quality** — The sources cited include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, industry newsletters (9amHealth, HCPlan), and expert commentary (Waltz on Lilly DTE), which collectively provide credible evidence for the VBC effectiveness and market competition arguments presented. 6. **Specificity** — No claims are being created or modified in this PR; the research journal contains falsifiable analytical statements (e.g., "market competition mechanisms are MARGINAL," "full capitation DOUBLED from 7% to 14%") but these are agent research notes, not formal claims requiring specificity review. ## Additional Observations The research journal session demonstrates rigorous disconfirmation methodology by testing Belief 3 against a market competition counter-argument and documenting quantitative evidence (MSSP $2.48B savings, quality metric improvements, capitation growth trajectory). The GLP-1 coverage crisis finding (3.6M → 2.8M covered lives) adds important nuance to existing claims about GLP-1 cost pressure. The MHPAEA mechanism finding (differential reimbursement treatment) provides the most precise explanation yet for mental health network gaps. No factual discrepancies detected between the journal narrative and the source material added. The synthesis accurately represents the evidence limitations (Lilly DTE "not revolutionary," Cost Plus partnering with incumbents rather than displacing them, price transparency limited to self-pay). <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 05:42:08 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-29 05:42:09 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 05:44:25 +00:00
m3taversal commented 2026-04-29 05:44:25 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#5515
No description provided.
Delete branch "vida/research-2026-04-29"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?